Find your path to Christopher
173 people in our graph share verified history with Christopher — schools, employers, funds. One of them is your warm intro.
Craig RosenbergunlockedChristopher: together at UCLA (1994)
×11Christopher: together at UCLA
About
Christopher Thanos is Chairman and CEO of XDemics Corporation, a Caltech spinout developing the High-Density Cell Respiration (HDCR) platform for cell culture. He has over 30 years of R&D experience, including 26 years in biotechnology, and is a named inventor on 35 issued patents and a first author of peer-reviewed articles in journals including Science, PNAS, and JACS. He co-founded Voro Therapeutics and Actym Therapeutics, where he raised $66M in initial capital and co-invented the clinical candidate ACTM-838, and previously contributed to platform technologies at Halozyme, Sutro Biopharma, and Catalyst Biosciences.
Executive at XDemics
Experience
- XDemics CorporationChairman and CEOcurrent2024 — presentCalifornia, United States
- Voro TherapeuticsCo-Foundercurrent2024 — presentBoston, Massachusetts, United States
- Actym Therapeutics, Inc.Senior Advisor, Scientific Advisory Board Member, Cofoundercurrent2024 — presentBerkeley, California, United States
- Actym Therapeutics, Inc.President, CEO and Cofounder2017 — 2024San Francisco Bay Area
- Halozyme Therapeutics, Inc.Senior Director, Biotherapeutics Discovery2015 — 2017
- Halozyme Therapeutics, Inc.Director, New Molecular Entities2013 — 2014San Diego, CA
- Sutro Biopharma, Inc.Director, Protein Engineering2011 — 2013South San Francisco, CA
- Catalyst BiosciencesCofounder2003 — 2011South San Francisco, CA
- UCSFNational Cancer Institute Postdoctoral Fellow2003San Francisco Bay Area
- Sunesis PharmaceuticalsNational Cancer Institute Postdoctoral Fellow2000 — 2003South San Francisco, CA
Skills & more
Protein Purification11Biochemistry36Protein Engineering15Molecular Biology27Drug Discovery33Strain Development4Protein Chemistry11Antibodies9Biopharmaceuticals17Biotechnology35Structural Biology5Lifesciences2
+8 more
Cell CultureCellPhage DisplayIn VitroClinical DevelopmentLife SciencesOncologyCell BiologyFrom Christopher's professional profile.
Frequently asked questions
- Who is Christopher Thanos?
- Christopher Thanos is Chairman and CEO of XDemics Corporation, a Caltech spinout developing the High-Density Cell Respiration (HDCR) platform for cell culture. He has over 30 years of R&D experience, including 26 years in biotechnology, and is a named inventor on 35 issued patents and a first author of peer-reviewed articles in journals including Science, PNAS, and JACS. He co-founded Voro Therapeutics and Actym Therapeutics, where he raised $66M in initial capital and co-invented the clinical candidate ACTM-838, and previously contributed to platform technologies at Halozyme, Sutro Biopharma, and Catalyst Biosciences.
- Where does Christopher Thanos work?
- Christopher Thanos is Executive at XDemics.
- Where did Christopher Thanos go to school?
- Christopher Thanos studied at UCLA (Ph.D., Molecular Biology and Biochemistry).
Same school
Also attended UCLA1,017
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzKirsten GreenFounder and Managing Partner at Forerunner VenturesVlad TenevCo-founder & CEO of RobinhoodRyan KingCo-founder of ChimePaul FieldingFinance & Operations at General CatalystMelody MaExecutive Assistant and Lead Receptionist at Trinity Ventures
+ 1,011 more
Shared employers
Also worked at Voro Therapeutics4
Also worked at Actym Therapeutics, Inc.2
Also worked at Sutro Biopharma, Inc.7
Patrick RiversPortfolio Manager at aMoonAlpana NareshChief Manufacturing Officer at Hinge BioJane ChungChief Executive Officer at SutrobioHans-Peter GerberChief Scientific Officer at SutrobioDavid PaulingChief Administrative Officer and General Counsel at SutrobioJonathan FawcettVP, Head of Clinical Development at Sutrobio
+ 1 more
Also worked at UCSF179
Logan HilleLife Sciences Analyst at CincyTechPaul JennyBoard Chair at CincyTechFrancisco GimenezInvestment Team at 8VCUlrik B. NielsenGeneral Partner at Mission BiocapitalHani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersCharles White, Ph.D.Principal at Illumina Ventures
+ 173 more